Results for:(157 found)
Mar 4, 2013 7:53AM on Top StocksBy Benzinga

US market are set for a lower open following weak data from China and ongoing concern Italians will have to go for another round of elections.

Feb 28, 2013 12:09PM on Top StocksBy TheStreet Staff

Pfizer has multiple health care businesses and Elan has Tysabri royalties and a would-be acquirer.

Feb 13, 2013 4:46AM on Top StocksBy Gene Marcial

This biotech behemoth's appeal is its combined value-and-growth stock characteristics.

Feb 7, 2013 1:01PM on Top StocksBy MSN Money Partner

Yahoo is upgraded to 'buy,' and Johnson & Johnson is downgraded to 'underperform.'

Jan 31, 2013 12:59PM on Top StocksBy MSN Money Partner

A great place to look for rising dividends is among energy master limited partnerships.

Jan 29, 2013 2:37PM on Top StocksBy Gene Marcial

The profitable biotech's two cancer drugs could make it an attractive target.

Jan 29, 2013 2:05PM on Top StocksBy MSN Money Partner

Stocks are mixed despite a consumer confidence reading that plunged to its lowest level in more than a year.

Jan 29, 2013 7:34AM on Top StocksBy Benzinga

Markets are set for a lower start following mixed quarterly results on Monday and ahead of results from Amazon, Corning and Ford.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More